EX-99.1 2 bglc_ex991.htm PRESS RELEASE bglc_ex991.htm EXHIBIT 99.1 BioNexus Gene Lab Corp. Calls for Malaysia - China Biotechnology Cooperation to Move Beyond Trade into Co-Development KUALA LUMPUR, Malaysia, May 29, 2026 - BioNexus Gene Lab Corp. (Nasdaq: BGLC) (“BioNexus” or the “Company”), a technology-focused company advancing innovation across biotechnology, precision diagnostics, and emerging healthcare platforms, today highlighted its participation in the 2026 China - Malaysia Economic Cooperation Outlook Forum, held on May 21, 2026 at the Mandarin Oriental Hotel in Kuala Lumpur. The forum, held under the theme “Advancing Biotechnology and Healthcare Collaboration towards a China - Malaysia Community with a Shared Future,” brought together government representatives, industry leaders, investors, healthcare professionals, and experts from Malaysia and China to discuss strategic cooperation across biotechnology, healthcare, pharmaceutical development, infrastructure, and related sectors. Sam Tan, Chief Executive Officer of BioNexus, participated as a speaker, where he discussed the opportunity to build a Malaysia - China precision healthcare corridor focused on moving…
Open exhibit ↗Current Report · Items 8.01, 9.01 · 8-K
BioNexus Gene Lab Corp
BGLCNASDAQEQUITYCurrent
Other Events
Item 8.01. Other Events On May 29, 2026, BioNexus Gene Lab Corp. (the “Company”) issued a press release titled “BioNexus Gene Lab Corp. Calls for Malaysia-China Biotechnology Cooperation to Move Beyond Trade into Co-Development,” highlighting the Company’s participation in the 2026 China-Malaysia Economic Cooperation Outlook Forum held on May 21, 2026 in Kuala Lumpur, Malaysia, and the Company’s v…
Company context
BioNexus Gene Lab Corp. (Nasdaq: BGLC) is a technology-focused company operating across biotechnology, precision diagnostics and specialty materials. Through its subsidiaries, investments and licensing arrangements, the Company is developing new healthcare and life-science businesses alongside its established operations.